[Skip to Content]
[Skip to Content Landing]
Other Articles
November 25, 1961

The Basic Position of Samuel Hahnemann

Author Affiliations

66 E. 83rd St., New York City 28

JAMA. 1961;178(8):863-864. doi:10.1001/jama.1961.03040470079020

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


To the Editor:—  Dr. Theodore Greiner in his article "Why We Rarely Know About Drugs" (JAMA177:42 [July 8] 1961) essentially restates the basic position of Samuel Hahnemann, the founder of clinical pharmacology. Dr. Greiner's statement, "A more sensible attitude would be to distinguish in what way patients and their diseases have a similar response to drugs. Once a common basis is clearly described, it serves as the starting point for developing each individual therapeutic regimen. It is the task of clinical pharmacology to furnish this common basis of drug response in a form immediately available for clinical use," might be from Hahnemann's Organon of Rational Healing published in Leipzig in 1810.Elsewhere, Dr. Greiner speaks of "The reaction against polypharmacy and its shotgun prescriptions... in the early 1800's.... During this cycle empirical observations were neglected..." Hahnemann is, of course, generally credited by medical historians (such as Garrison) to

First Page Preview View Large
First page PDF preview
First page PDF preview